Alex Fässler
Fortune : 3 M $ au 30/06/2026
Fortune : 3 M $ au 30/06/2026
Alex Fässler is currently the Head of Operations at Targimmune Therapeutics AG.
Previously, he worked as the Chief Operating Officer at Bachem Holding AG and as the Head of Production & Site Manager at Bachem AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 33 580 ( 0,04 % ) | 3 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Directeur des opérations | - |
| Sociétés | Poste | Fin |
|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Corporate Officer/Principal | - |
| BACHEM HOLDING AG | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Bachem Holding AG
Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national